Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

28.86 -0.82 (-2.76%)

Streaming Delayed Price Updated: 12:15 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

48 49 Next >

MarketBeat Week in Review – 03/03 - 03/07

March 08, 2025

Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue

Via MarketBeat

Topics Economy

This Could Be a Huge Blow to Hims & Hers Health Stock ↗

March 07, 2025

Via The Motley Fool

Forecasting The Future: 15 Analyst Projections For Hims & Hers Health ↗

March 06, 2025

Via Benzinga

Why Hims & Hers Stock Just Collapsed ↗

March 06, 2025

Via The Motley Fool

Market Whales and Their Recent Bets on HIMS Options ↗

March 06, 2025

Via Benzinga

Why Hims & Hers Health Stock Sank This Week ↗

February 28, 2025

Via The Motley Fool

Hims & Hers Health Unusual Options Activity For February 28 ↗

February 28, 2025

Via Benzinga

Hims Stock Crashed After Earnings. What Went Wrong? ↗

February 25, 2025

Via The Motley Fool

Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It ↗

March 05, 2025

Via The Motley Fool

Why Is Hims & Hers Health Stock Trading Lower On Wednesday? ↗

March 05, 2025

Hims & Hers Health stock drops over 20% after the FDA removes semaglutide from the shortage list. Novo Nordisk launches a direct delivery service for Wegovy.

Via Benzinga

Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health ↗

March 05, 2025

The news slammed Hims stock. Hims & Hers sells knockoff versions of semaglutide, the chemical backbone behind Wegovy.

Via Investor's Business Daily

Missed the Hims & Hers Rally? Clover Health Could Be Next

March 05, 2025

After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space.

Via MarketBeat

EXCLUSIVE: February's 20 Most-Searched Tickers On Benzinga Pro – Where Do Tesla, Palantir, Alibaba, Nvidia Rank? ↗

March 04, 2025

These were the 20 tickers that Benzinga readers searched for the most during the month of February.

Via Benzinga

Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath ↗

March 04, 2025

U.S. markets suffered a steep selloff Monday as President Donald Trump announced sweeping new tariffs, extending last week's losses and driving declines across all major sectors.

Via Benzinga

Topics Government World Trade

Short Term Relief Likely ↗

March 02, 2025

Post earnings has seen little bullish follow-through, and this typically means the broad market won’t have much to shout about over the coming weeks.

Via Talk Markets

Topics ETFs Stocks / Equities

Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock? ↗

March 01, 2025

Via The Motley Fool

Sixty Percent Of The Time, It Works Every Time ↗

February 28, 2025

The past few weeks have brought a dramatic change in investor sentiment.

Via Talk Markets

Topics Stocks / Equities

Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up ↗

February 28, 2025

Can Hims & Hers Health recover after the FDA removed semaglutide from its drugs shortage list?

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

February 27, 2025

Via Benzinga

NVDA Earnings And The State Of The Market ↗

February 26, 2025

Nvidia reported its much anticipated 4Q earnings after the close. It was a mixed bag.

Via Talk Markets

Topics Stocks / Equities

Why Hims & Hers Stock Rebounded on Wednesday ↗

February 26, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 26, 2025

Via Benzinga

Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now

February 26, 2025

See why these two high-flying stocks are among the most shorted in the market, plus counterarguments amid bearish gripes.

Via MarketBeat

GoodRx Earnings: What To Look For From GDRX

February 26, 2025

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results tomorrow before the bell. Here’s what investors should know.

Via StockStory

Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings ↗

February 25, 2025

Via Benzinga

Topics Stocks

Hims & Hers Health Analyst Sees Buying Opportunity Following Steep Selloff: 'We See No Reason To Change Our View' ↗

February 25, 2025

Hims & Hers Health Inc. (NYSE: HIMS) shares dropped sharply after the company reported its fourth-quarter earnings. Here's what you need to know.

Via Benzinga

Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today

February 25, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 27.6% in the afternoon session after the company delivered mixed fourth-quarter 2024 results: It added fewer customers than expected,...

Via StockStory

Which stocks are experiencing notable movement on Tuesday? ↗

February 25, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday? ↗

February 25, 2025

Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a...

Via Benzinga

Topics Stocks

Hims & Hers Stock Crashed 26% Today. Here's What You Need to Know ↗

February 25, 2025

Hims & Hers grew 95% in the fourth quarter of 2024, but investors were worried about GLP-1 growth.

Via The Motley Fool

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.